| Therapeutic effects of marine collagen peptides on Chinese patients with type 2 diabetes mellitus and primary hypertension. | |
| | |
MedLine Citation:
|
PMID: 20739874 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
INTRODUCTION: Marine collagen peptides (MCPs) from deep sea fish are shown to ameliorate hyperlipidemia in animal models. The study aimed at examining the effects of MCPs on glucose and lipid metabolism in Chinese patients with type 2 diabetes mellitus (T2DM) and primary hypertension. METHODS: One hundred patients with T2DM and primary hypertension and 50 healthy subjects (normal controls) were recruited for a randomized double blind study. The patients were randomized into MCPs treatment or patient control groups (n = 50 per group). Both patient controls and normal controls were given carboxymethylcellulose twice daily whereas the MCPs treatment group was given MCPs twice daily for 3 months. Blood pressure, glucose and lipid metabolism, serum high-sensitivity C-reactive protein, cytochrome P450, nitric oxide, bradykinin, prostacyclin, creatinine, uric acid and adipokines were measured at baseline, 1.5 and 3 months after treatment. All patients received regular medicines for control of hyperglycemia and hypertension. RESULTS: Compared with patient controls, significantly reduced levels of fasting blood glucose, HbA1c, diastolic blood pressure, mean arterial pressure and creatinine but increased levels of Insulin Sensitivity Index and Insulin Secretion Index were observed in patients receiving MCPs treatment. Furthermore, significantly reduced levels of serum triglycerides, total cholesterol, low-density lipoprotein, free fatty acids, cytochrome P450, nitric oxide and prostacyclin but increased levels of high-density lipoprotein, bradykinin and adiponectin were detected in patients taking MCPs. CONCLUSIONS: MCPs supplement may benefit glucose and lipid metabolism, insulin sensitivity, renal function and hypertension management in Chinese patients with T2DM and hypertension. |
| | |
Authors:
|
Cui-Feng Zhu; Guan-Zhi Li; Hong-Bin Peng; Fan Zhang; Yun Chen; Yong Li |
Related Documents
:
|
15030294 - At1-receptor antagonism in hypertension: what has been learned with irbesartan? 19491704 - Trends in blood pressure control and treatment among type 2 diabetes with comorbid hype... 10333344 - Role of insulin resistance in the genesis of sodium sensitivity in essential hypertension. 11327624 - Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related h... 10401224 - Alterations in retrograde axonal transport in optic nerve of type i and type ii diabeti... 18943444 - Recessive resistance to septoria stem canker of hybrid poplar. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The American journal of the medical sciences Volume: 340 ISSN: 1538-2990 ISO Abbreviation: Am. J. Med. Sci. Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-04 Completed Date: 2010-12-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370506 Medline TA: Am J Med Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 360-6 Citation Subset: AIM; IM |
Affiliation:
|
Department of Nutrition, Shenzhen Hospital of Peking University, Shenzhen, People's Republic of China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Animals Asian Continental Ancestry Group Blood Glucose / drug effects Blood Pressure / drug effects Collagen / pharmacology, therapeutic use* Diabetes Mellitus, Type 2 / drug therapy* Double-Blind Method Female Humans Hypertension / drug therapy* Lipid Metabolism / drug effects Male Middle Aged Peptides / pharmacology, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Peptides; 9007-34-5/Collagen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Aspirin desensitization/challenge in 3 patients with unstable angina.
Next Document: Coincidence of Multiple Endocrine Neoplasia Type 2A With Acromegaly.